News | October 12, 2021
Tarsons earmarks funds from IPO to double capacity at its Panchla facility
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects
Subscribe To Our Newsletter & Stay Updated
